FdaApplication
ANDA 206271
Identifiers
- fda_app_no: ANDA206271
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2015-11-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEVIRAPINE | NEVIRAPINE | 100MG | TABLET, EXTENDED RELEASE;ORAL |
1 product